Mengs U - Search Results

1

The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.

Semiglasov VF, Stepula VV, Dudov A, Lehmacher W, Mengs U. Semiglasov VF, et al. Among authors: mengs u. Anticancer Res. 2004 Mar-Apr;24(2C):1293-302. Anticancer Res. 2004. PMID: 15154663 Free article. Clinical Trial.

2

Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.

Elsässer-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U. Elsässer-Beile U, et al. Among authors: mengs u. J Urol. 2005 Jul;174(1):76-9. doi: 10.1097/01.ju.0000163261.08619.d0. J Urol. 2005. PMID: 15947582 Clinical Trial.

3

Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.

Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U. Elsässer-Beile U, et al. Among authors: mengs u. Anticancer Res. 2005 Nov-Dec;25(6C):4733-6. Anticancer Res. 2005. PMID: 16334168 Free article. Clinical Trial.

4

Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.

Elsässer-Beile U, Ruhnau T, Freudenberg N, Wetterauer U, Mengs U. Elsässer-Beile U, et al. Among authors: mengs u. Cancer. 2001 Mar 1;91(5):998-1004. Cancer. 2001. PMID: 11251952

5

Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.

Semiglazov VF, Stepula VV, Dudov A, Schnitker J, Mengs U. Semiglazov VF, et al. Among authors: mengs u. Anticancer Res. 2006 Mar-Apr;26(2B):1519-29. Anticancer Res. 2006. PMID: 16619567 Free article. Clinical Trial.

6

Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models.

Burger AM, Mengs U, Schüler JB, Fiebig HH. Burger AM, et al. Among authors: mengs u. Anticancer Res. 2001 May-Jun;21(3B):1965-8. Anticancer Res. 2001. PMID: 11497284

7

Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.

Dohmen W, Breier M, Mengs U. Dohmen W, et al. Among authors: mengs u. Anticancer Res. 2004 Mar-Apr;24(2C):1231-7. Anticancer Res. 2004. PMID: 15154652 Free article. Clinical Trial.

8

No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.

Burger AM, Mengs U, Kelter G, Schüler JB, Fiebig HH. Burger AM, et al. Among authors: mengs u. Anticancer Res. 2003 Sep-Oct;23(5A):3801-6. Anticancer Res. 2003. PMID: 14666680

9

Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.

Schaffrath B, Mengs U, Schwarz T, Hilgers RD, Beuth J, Möckel B, Lentzen H, Gerstmayer B. Schaffrath B, et al. Among authors: mengs u. Anticancer Res. 2001 Nov-Dec;21(6A):3981-7. Anticancer Res. 2001. PMID: 11911280

10

[Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].

Mengs U, Witthohn K, Schwarz T, Lentzen H. Mengs U, et al. Wien Med Wochenschr. 1999;149(8-10):262-4. Wien Med Wochenschr. 1999. PMID: 10483695 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results